CTKB · Cytek Biosciences, Inc.
Cytek Biosciences Inc (CTKB)
What's happening
- CTKB is up 3.19% today, trading at $5.50. — Live quote
- Volume today (89,740) is well below its 3-month average of 1,352,760. (Finnhub fundamentals)
- Reports earnings on 2026-11-11 (after market close), 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.08 actual vs. $-0.09 estimated (+7.7%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Aggregate ratings for 2026-10-01 (10 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Earnings Trends (Quarterly EPS Actual vs Estimate)
Valuation Measures & Ratios
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 5.6% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +32.2%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -39.0%. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-09-29; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on CTKB
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $48.1M | $44.1M | $52.3M | $45.6M | $41.5M | $51.5M | $46.6M | $44.9M |
| Gross profit | $28.3M | $21.3M | $27.6M | $23.9M | $20.2M | $29.0M | $25.4M | $23.0M |
| Operating income | -$11.4M | -$18.5M | -$9.2M | -$10.6M | -$15.0M | -$4.2M | -$8.5M | -$10.7M |
| Net income | -$12.2M | -$18.9M | — | -$5.6M | -$11.4M | — | — | -$6.2M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| EPS (basic) | — | — | — | — | — | — | — | — |
| Operating margin | -$24 | -$42 | -$18 | -$23 | -$36 | -$8 | -$18 | -$24 |
| Net margin | -$25 | -$43 | — | -$12 | -$28 | — | — | -$14 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $446.9M | $449.1M | $461.5M | $494.9M | $493.3M | $482.6M | $499.5M | $491.2M |
| Total liabilities | $125.0M | $121.5M | $119.8M | $116.3M | $115.8M | $103.0M | $103.8M | $105.8M |
| Stockholders' equity | $322.0M | $327.6M | $341.7M | $378.6M | $377.6M | $379.6M | $395.7M | $385.5M |
| Total current assets | $377.9M | $379.3M | $392.0M | $388.5M | $382.8M | $380.5M | $396.4M | $390.2M |
| Total current liabilities | $84.3M | $80.9M | $77.8M | $75.2M | $73.3M | $67.7M | $67.7M | $62.8M |
| Cash & equivalents | $73.8M | $65.7M | $90.9M | $93.3M | $75.5M | $95.3M | $98.7M | $162.3M |
| Accounts receivable | $49.7M | $51.9M | $62.5M | $56.6M | $56.2M | $55.0M | $60.6M | $52.6M |
| Inventory | $52.3M | $49.8M | $48.4M | $51.6M | $49.5M | $45.3M | $43.9M | $46.8M |
| Other current assets | $5.5M | $3.6M | $3.0M | $2.9M | $2.8M | $2.3M | $1.9M | $2.3M |
| Property, plant & equipment | $20.8M | $20.5M | $18.0M | $18.0M | $18.4M | $17.8M | $18.0M | $18.5M |
| Goodwill | $16.7M | $16.7M | $16.7M | $16.7M | $16.7M | $16.7M | $16.7M | $16.2M |
| Intangible assets | $14.9M | $15.7M | $16.8M | $17.7M | $18.6M | $19.4M | $20.1M | $20.5M |
| Other non-current assets | $5.7M | $6.3M | $6.7M | $4.5M | $4.7M | $4.6M | $4.8M | $5.0M |
| Accrued liabilities | $23.9M | $19.8M | $23.4M | $20.2M | $21.6M | $19.2M | $21.4M | $20.7M |
| Deferred revenue (current) | $29.2M | $30.0M | $28.5M | $28.7M | $28.1M | $27.7M | $25.5M | $40.2M |
| Other current liabilities | $20.5M | $22.2M | $17.0M | $16.4M | $14.7M | $12.8M | $13.5M | $8.8M |
| Other non-current liabilities | $2.5M | $2.4M | $2.3M | $2.5M | $2.5M | $2.4M | $2.4M | $2.1M |
| Common stock & paid-in capital | $130.0K | $129.0K | $129.0K | $128.0K | $127.0K | $128.0K | $129.0K | $130.0K |
| Retained earnings | -$132.8M | -$120.6M | -$101.7M | -$57.7M | -$52.2M | -$46.6M | -$35.2M | -$44.8M |
| Accumulated other comprehensive income (loss) | $2.7M | $2.4M | $2.2M | $821.0K | -$38.0K | -$609.0K | $16.0K | $101.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.4M | -$2.7M | -$771.0K | -$3.9M | $108.0K | -$125.0K | $2.0M | $13.2M |
| Investing cash flow | $7.0M | -$27.1M | -$1.8M | $18.9M | -$16.4M | $9.5M | -$63.4M | -$15.8M |
| Financing cash flow | -$814.0K | $4.0M | -$1.2M | $1.9M | -$2.6M | -$11.5M | -$3.6M | -$12.1M |
| Free cash flow | -$849.0K | -$4.9M | -$1.8M | -$4.6M | -$1.5M | -$974.0K | $1.1M | $12.2M |
| Capital expenditures | $2.2M | $2.2M | $1.0M | $657.0K | $1.6M | $849.0K | $894.0K | $1.0M |
| Depreciation & amortization | $2.0M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M |
| Share-based compensation | $5.3M | $4.9M | $5.5M | $5.6M | $6.8M | $6.6M | $7.0M | $7.1M |
| Deferred income taxes | $0 | -$183.0K | $38.6M | -$2.6M | -$2.1M | -$336.0K | -$2.9M | $0 |
| Change in accounts receivable | -$2.0M | -$9.6M | $6.1M | $587.0K | -$652.0K | -$6.4M | $9.3M | $6.3M |
| Change in inventory | $2.9M | $1.6M | -$2.1M | $2.2M | $3.6M | $1.5M | -$2.0M | -$3.6M |
| Change in accounts payable | $1.7M | $390.0K | -$1.3M | $588.0K | $759.0K | $410.0K | $258.0K | $2.2M |
| Share repurchases | $0 | $0 | -$34.0K | -$29.0K | $4.5M | $10.6M | $7.0M | $11.9M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $201.5M | $200.5M | $193.0M | $164.0M | $128.0M |
| Gross profit | $104.5M | $111.1M | $109.4M | $101.0M | $79.1M |
| Operating income | -$40.4M | -$20.5M | -$27.8M | -$1.8M | $9.2M |
| Net income | -$66.5M | -$6.0M | -$12.1M | $2.5M | $3.0M |
| EPS (diluted) | — | — | $-0.09 | $0.02 | $0.00 |
| EPS (basic) | — | — | $-0.09 | $0.02 | $0.00 |
| Operating margin | -$20 | -$10 | -$14 | -$1 | $7 |
| Net margin | -$33 | -$3 | -$6 | $2 | $2 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $461.5M | $499.5M | $494.5M | $519.5M | $463.3M |
| Total liabilities | $119.8M | $103.8M | $101.4M | $93.9M | $57.9M |
| Stockholders' equity | $341.7M | $395.7M | $393.1M | $425.5M | $405.4M |
| Total current assets | $392.0M | $396.4M | $392.1M | $454.0M | $431.7M |
| Total current liabilities | $77.8M | $67.7M | $56.2M | $49.0M | $33.2M |
| Cash & equivalents | $90.9M | $98.7M | $167.3M | $296.6M | $364.6M |
| Accounts receivable | $62.5M | $60.6M | $55.9M | $48.9M | $29.8M |
| Inventory | $48.4M | $43.9M | $60.9M | $48.2M | $32.2M |
| Other current assets | $3.0M | $1.9M | $2.2M | $3.8M | $708.0K |
| Property, plant & equipment | $18.0M | $18.0M | $18.4M | $13.7M | $5.9M |
| Goodwill | $16.7M | $16.7M | $16.2M | $10.1M | $10.1M |
| Intangible assets | $16.8M | $20.1M | $23.1M | $4.3M | $4.7M |
| Other non-current assets | $6.7M | $4.8M | $3.4M | $3.0M | $1.7M |
| Accrued liabilities | $23.4M | $21.4M | $20.0M | $21.1M | $15.3M |
| Deferred revenue (current) | $28.5M | $25.5M | $22.7M | $26.1M | $16.9M |
| Other current liabilities | $17.0M | $13.5M | $7.9M | $8.0M | $6.4M |
| Other non-current liabilities | $2.3M | $2.4M | $2.4M | $1.6M | $1.2M |
| Common stock & paid-in capital | $129.0K | $129.0K | $131.0K | $135.0K | $126.0K |
| Retained earnings | -$101.7M | -$35.2M | -$29.2M | -$17.0M | -$19.6M |
| Accumulated other comprehensive income (loss) | $2.2M | $16.0K | -$1.3M | -$697.0K | $897.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$4.7M | $25.4M | $5.3M | -$12.2M | $4.6M |
| Investing cash flow | $10.1M | -$83.0M | -$93.9M | -$55.9M | -$21.0M |
| Financing cash flow | -$13.4M | -$15.8M | -$41.8M | $5.5M | $213.6M |
| Free cash flow | -$8.8M | $21.9M | $633.0K | -$22.0M | $266.0K |
| Capital expenditures | $4.1M | $3.5M | $4.6M | $9.7M | $4.4M |
| Depreciation & amortization | $7.6M | $7.2M | $6.0M | $2.5M | $1.2M |
| Share-based compensation | $24.6M | $26.8M | $22.0M | $16.6M | $6.6M |
| Deferred income taxes | $33.6M | -$2.9M | $0 | $0 | -$1.8M |
| Change in accounts receivable | -$368.0K | $5.4M | $7.3M | $19.7M | $12.4M |
| Change in inventory | $5.2M | -$14.8M | -$4.3M | $17.7M | $7.1M |
| Change in accounts payable | $448.0K | $2.6M | -$1.8M | $1.9M | -$256.0K |
| Share repurchases | $15.1M | $21.6M | $44.2M | $0 | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding CTKB as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9,578,643 | $42.4M | 7.37% | -43.7% | 2026-08-07 |
| MILLENNIUM MANAGEMENT LLC | 9,338,010 | $41.4M | 7.18% | +48.4% | 2026-08-14 |
| Boston Partners | 7,660,943 | $33.9M | 5.89% | +32.0% | 2026-08-04 |
| HHLR ADVISORS, LTD. | 6,657,030 | $29.5M | 5.12% | +0.0% | 2026-08-14 |
| Topline Capital Management, LLC | 6,283,450 | $27.8M | 4.83% | -11.1% | 2026-08-14 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,939,597 | $21.9M | 3.80% | +3.7% | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,059,573 | $13.6M | 2.35% | +8.0% | 2026-08-12 |
| DIMENSIONAL FUND ADVISORS LP | 2,616,257 | $11.6M | 2.01% | -1.8% | 2026-08-11 |
| State Street Corp | 2,566,121 | $11.4M | 1.97% | -37.8% | 2026-08-07 |
| Goldman Sachs Group Inc | 2,167,515 | $9.6M | 1.67% | -7.6% | 2026-08-14 |
| ROYCE & ASSOCIATES LP | 2,081,579 | $9.2M | 1.60% | +26.7% | 2026-08-14 |
| Russell Investments Group, Ltd. | 1,511,315 | $6.7M | 1.16% | +11.1% | 2026-08-05 |
| ACADIAN ASSET MANAGEMENT LLC | 1,376,048 | $6.1K | 1.06% | +244.9% | 2026-08-12 |
| Bank Of America Corp /De/ | 1,315,332 | $5.8M | 1.01% | +30.4% | 2026-08-14 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,141,592 | $5.1M | 0.88% | -50.6% | 2026-06-30 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,073,253 | $4.8M | 0.83% | -2.8% | 2026-08-14 |
| Northern Trust Corp | 1,003,294 | $4.4M | 0.77% | -0.2% | 2026-08-12 |
| HRT FINANCIAL LP | 997,769 | $4.4K | 0.77% | +141.0% | 2026-08-14 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 973,833 | $4.3M | 0.75% | +204.4% | 2026-08-13 |
| JANE STREET GROUP, LLC | 906,162 | $4.0M | 0.70% | +0.0% | 2026-08-14 |
| TUDOR INVESTMENT CORP ET AL | 837,913 | $3.7M | 0.64% | +161.3% | 2026-08-14 |
| AQR CAPITAL MANAGEMENT LLC | 813,971 | $3.6M | 0.63% | -10.8% | 2026-08-14 |
| VANGUARD FIDUCIARY TRUST CO | 740,662 | $3.3M | 0.57% | +3.3% | 2026-06-30 |
| CITADEL ADVISORS LLC | 721,470 | $3.2M | 0.56% | +53.1% | 2026-08-14 |
| Morgan Stanley | 701,792 | $3.1M | 0.54% | -59.2% | 2026-08-11 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-10 to 2026-08-18
Recent transactions
- Most recent: Jiang Wenbin (PRESIDENT AND CEO) — Option exercise of 11,781 shares on 2026-08-18.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Jiang Wenbin | PRESIDENT AND CEO | Option exercise | 2026-08-18 | 11,781 |
| McCombe William D. | Chief Financial Officer | Option exercise | 2026-08-18 | 6,320 |
| MUIR GLENN P | Reporting person | Option exercise | 2026-08-18 | 3,086 |
| Holder Michael | Reporting person | Option exercise | 2026-08-18 | 2,181 |
| Chin Richard | Reporting person | Option exercise | 2026-08-18 | 6,107 |
| Yan Ming | CHIEF TECHNOLOGY OFFICER | Option exercise | 2026-08-18 | 7,363 |
| Ball Jack | Reporting person | Option exercise | 2026-06-10 | 43,973 |
| Imper Vera | Reporting person | Option exercise | 2026-06-10 | 43,973 |
| NEFF DEBORAH J | Reporting person | Option exercise | 2026-06-10 | 43,973 |
| Busque Philippe | SVP, GLOBAL SALES AND SERVICES | Option exercise | 2026-05-18 | 1,024 |
| Barnett Valerie | CHIEF LEGAL OFFICER | Option exercise | 2026-05-18 | 2,454 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-18 | Jiang Wenbin | PRESIDENT AND CEO | Option exercise | 11,781 | — |
| 2026-08-18 | Jiang Wenbin | PRESIDENT AND CEO | Tax withholding | 2,869 | $4.67 |
| 2026-08-18 | Jiang Wenbin | PRESIDENT AND CEO | Option exercise | 22,100 | — |
| 2026-08-18 | Jiang Wenbin | PRESIDENT AND CEO | Tax withholding | 5,382 | $4.67 |
| 2026-08-18 | Jiang Wenbin | PRESIDENT AND CEO | Option exercise | 29,002 | — |
| 2026-08-18 | Jiang Wenbin | PRESIDENT AND CEO | Tax withholding | 7,062 | $4.67 |
| 2026-08-18 | Jiang Wenbin | PRESIDENT AND CEO | Option exercise | 57,212 | — |
| 2026-08-18 | Jiang Wenbin | PRESIDENT AND CEO | Tax withholding | 20,956 | $4.67 |
| 2026-08-18 | McCombe William D. | Chief Financial Officer | Option exercise | 6,320 | — |
| 2026-08-18 | McCombe William D. | Chief Financial Officer | Tax withholding | 2,111 | $4.67 |
| 2026-08-18 | McCombe William D. | Chief Financial Officer | Option exercise | 13,051 | — |
| 2026-08-18 | McCombe William D. | Chief Financial Officer | Tax withholding | 4,392 | $4.67 |
| 2026-08-18 | McCombe William D. | Chief Financial Officer | Option exercise | 16,049 | — |
| 2026-08-18 | McCombe William D. | Chief Financial Officer | Tax withholding | 5,401 | $4.67 |
| 2026-08-18 | MUIR GLENN P | Reporting person | Option exercise | 3,086 | — |
| 2026-08-18 | Holder Michael | Reporting person | Option exercise | 2,181 | — |
| 2026-08-18 | Chin Richard | Reporting person | Option exercise | 6,107 | — |
| 2026-08-18 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Option exercise | 7,363 | — |
| 2026-08-18 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Tax withholding | 1,778 | $4.67 |
| 2026-08-18 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Option exercise | 5,525 | — |
| 2026-08-18 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Tax withholding | 1,346 | $4.67 |
| 2026-08-18 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Option exercise | 6,162 | — |
| 2026-08-18 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Tax withholding | 1,501 | $4.67 |
| 2026-08-18 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Option exercise | 14,220 | — |
| 2026-08-18 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Tax withholding | 3,463 | $4.67 |
| 2026-06-12 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Gift | 135,892 | $0.00 |
| 2026-06-10 | Ball Jack | Reporting person | Option exercise | 43,973 | — |
| 2026-06-10 | Imper Vera | Reporting person | Option exercise | 43,973 | — |
| 2026-06-10 | NEFF DEBORAH J | Reporting person | Option exercise | 43,973 | — |
| 2026-06-10 | Holder Michael | Reporting person | Option exercise | 43,973 | — |
| 2026-05-18 | Holder Michael | Reporting person | Option exercise | 1,454 | — |
| 2026-05-18 | Chin Richard | Reporting person | Option exercise | 6,107 | — |
| 2026-05-18 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Option exercise | 4,908 | — |
| 2026-05-18 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Tax withholding | 1,224 | $3.55 |
| 2026-05-18 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Option exercise | 3,683 | — |
| 2026-05-18 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Tax withholding | 919 | $3.55 |
| 2026-05-18 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Option exercise | 4,108 | — |
| 2026-05-18 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Tax withholding | 1,025 | $3.55 |
| 2026-05-18 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Option exercise | 9,480 | — |
| 2026-05-18 | Yan Ming | CHIEF TECHNOLOGY OFFICER | Tax withholding | 2,364 | $3.55 |
| 2026-05-18 | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | Option exercise | 1,024 | — |
| 2026-05-18 | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | Tax withholding | 263 | $3.55 |
| 2026-05-18 | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | Option exercise | 1,473 | — |
| 2026-05-18 | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | Tax withholding | 378 | $3.55 |
| 2026-05-18 | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | Option exercise | 2,416 | — |
| 2026-05-18 | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | Tax withholding | 620 | $3.55 |
| 2026-05-18 | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | Option exercise | 5,551 | — |
| 2026-05-18 | Busque Philippe | SVP, GLOBAL SALES AND SERVICES | Tax withholding | 1,424 | $3.55 |
| 2026-05-18 | Jiang Wenbin | PRESIDENT AND CEO | Option exercise | 7,854 | — |
| 2026-05-18 | Jiang Wenbin | PRESIDENT AND CEO | Tax withholding | 1,913 | $3.55 |
| 2026-05-18 | Jiang Wenbin | PRESIDENT AND CEO | Option exercise | 14,733 | — |
| 2026-05-18 | Jiang Wenbin | PRESIDENT AND CEO | Tax withholding | 3,588 | $3.55 |
| 2026-05-18 | Jiang Wenbin | PRESIDENT AND CEO | Option exercise | 19,334 | — |
| 2026-05-18 | Jiang Wenbin | PRESIDENT AND CEO | Tax withholding | 5,032 | $3.55 |
| 2026-05-18 | Jiang Wenbin | PRESIDENT AND CEO | Option exercise | 38,141 | — |
| 2026-05-18 | Jiang Wenbin | PRESIDENT AND CEO | Tax withholding | 15,009 | $3.55 |
| 2026-05-18 | McCombe William D. | Chief Financial Officer | Option exercise | 6,320 | — |
| 2026-05-18 | McCombe William D. | Chief Financial Officer | Tax withholding | 2,268 | $3.55 |
| 2026-05-18 | McCombe William D. | Chief Financial Officer | Option exercise | 8,700 | — |
| 2026-05-18 | McCombe William D. | Chief Financial Officer | Tax withholding | 3,122 | $3.55 |
Showing the most recent 60 transactions.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 02:11 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-29 | 8-K | 2026-09-23 | View on SEC.gov → |
| 2026-08-24 | 8-K | 2026-08-21 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-08-05 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-07-15 | 8-K | 2026-07-09 | View on SEC.gov → |
Recent news
Headlines about CTKB (Cytek Biosciences, Inc.). Links open the publisher — we don’t host full articles.
-
Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026
Yahoo Finance · 2026-10-21 -
Cytek Biosciences stock gains 4.08 percent versus Tradegate close
AD HOC NEWS · 2026-10-20 -
Responsive Playbooks and the CTKB Inflection
Stock Traders Daily · 2026-10-19 -
Morgan Stanley keeps USD 5.00 target for Cytek Biosciences stock
AD HOC NEWS · 2026-10-17 -
Cytek Biosciences Stock Price Forecast. Should You Buy CTKB?
StockInvest.us · 2026-10-16 -
Fund Divests Cytek Biosciences (CTKB) Following Revenue Slowdown and Declining Profitability
Yahoo Finance · 2026-09-29 -
Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
Yahoo Finance · 2026-09-23 -
Is the Options Market Predicting a Spike in Cytek Biosciences Bank Stock?
Yahoo Finance · 2026-09-17
No headlines in this category right now — try “All”.